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The HTLV-1 ORF-1-encoded p12 protein induces T-cell
activation and proliferation, while the cleaved p8 protein
downregulates TCR signaling. In this study, we investi-
gated whether there is a correlation between genetic
variation within ORF-1 and the clinical status or pro-
viral load in HTLV-1 infected individuals. The ORF-1
gene was amplified by PCR from PBMCs of 163 HTLV-
1-infected patients (85 carriers, 78 HAM/TSP) from dif-
ferent geographical regions and a total of 1,640 clones
were sequenced. The majority of the patients (73%) car-
ried mutations in ORF-1 that resulted in the expression
of more p12 than p8 (50% Carriers and 50% HAM/
TSP). The highest genetic variability within ORF-1 was
found in the two transmembrane domains of the pro-
tein. Of interest, a subclass of mutations was found
more frequently in HAM/TSP patients compared to
Carriers. While higher proviral loads were found in
HAM/TSP patients compared to Carriers (p=0.0001), no
correlation between proviral load and the ORF-1 iso-
form expressed was observed (mainly p12, both p12 and
p 8 ,o rm a i n l yp 8 ) .C u r r e n t l yexperiments are aimed at
determining the significance of these mutations in ORF-
1 function in regard to T-cell activation and prolifera-
tion. In addition, mutations will be characterized for
their role in viral infectivity and transmission rates ex
vivo and in a rhesus macaque model. Determining the
effects of ORF-1 mutants on viral replication, spread
and latency will provide insight into the pathogenesis of
HTLV-1 infection.
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